DK0707591T3 - Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse - Google Patents

Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse

Info

Publication number
DK0707591T3
DK0707591T3 DK94919670T DK94919670T DK0707591T3 DK 0707591 T3 DK0707591 T3 DK 0707591T3 DK 94919670 T DK94919670 T DK 94919670T DK 94919670 T DK94919670 T DK 94919670T DK 0707591 T3 DK0707591 T3 DK 0707591T3
Authority
DK
Denmark
Prior art keywords
preparation
acid esters
pct
phosphonic acid
methyl phosphonic
Prior art date
Application number
DK94919670T
Other languages
Danish (da)
English (en)
Inventor
Eugen Uhlmann
Chris Meier
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0707591T3 publication Critical patent/DK0707591T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
DK94919670T 1993-07-01 1994-06-29 Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse DK0707591T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4321946A DE4321946A1 (de) 1993-07-01 1993-07-01 Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP1994/002121 WO1995001363A1 (de) 1993-07-01 1994-06-29 Methylphosphonsäureester, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
DK0707591T3 true DK0707591T3 (da) 2002-01-21

Family

ID=6491730

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919670T DK0707591T3 (da) 1993-07-01 1994-06-29 Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse

Country Status (13)

Country Link
US (1) US6028182A (ja)
EP (1) EP0707591B1 (ja)
JP (1) JP3831407B2 (ja)
AT (1) ATE206130T1 (ja)
AU (1) AU698928B2 (ja)
CA (1) CA2165971C (ja)
DE (2) DE4321946A1 (ja)
DK (1) DK0707591T3 (ja)
ES (1) ES2165391T3 (ja)
FI (1) FI115399B (ja)
NO (1) NO319860B1 (ja)
PT (1) PT707591E (ja)
WO (1) WO1995001363A1 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
DE4331670A1 (de) * 1993-09-17 1995-03-23 Hoechst Ag Neue Antisense-Oligonucleotide gegen HSV-1 sowie deren Herstellung
DE4338704A1 (de) 1993-11-12 1995-05-18 Hoechst Ag Stabilisierte Oligonucleotide und deren Verwendung
DE19502912A1 (de) * 1995-01-31 1996-08-01 Hoechst Ag G-Cap Stabilisierte Oligonucleotide
PT739898E (pt) * 1995-03-13 2002-03-28 Aventis Pharma Gmbh Mono-esteres de acidos fosfonucleicos processo para a sua preparacao e sua utilizacao
US5821354A (en) * 1996-11-26 1998-10-13 Angiogene Inc. Radiolabeled DNA oligonucleotide and method of preparation
US6248878B1 (en) 1996-12-24 2001-06-19 Ribozyme Pharmaceuticals, Inc. Nucleoside analogs
EP0948511B1 (en) * 1996-12-24 2006-10-18 Sirna Therapeutics, Inc. Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
NZ513935A (en) 1999-02-17 2004-02-27 Csl Ltd Immunogenic complexes and methods relating thereto
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US20020119178A1 (en) * 2001-02-23 2002-08-29 Luc Levesque Drug eluting device for treating vascular diseases
GB0110732D0 (en) * 2001-05-02 2001-06-27 Psl Technology Ltd Apparatus and method
AR040996A1 (es) 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
EP2241325B1 (en) 2002-10-29 2012-02-08 Coley Pharmaceutical Group, Inc. Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
CA2555390C (en) 2004-02-19 2014-08-05 Coley Pharmaceutical Group, Inc. Immunostimulatory viral rna oligonucleotides
KR20100018029A (ko) 2004-07-18 2010-02-16 씨에스엘 리미티드 면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기 위한 올리고뉴클레오티드 제제
CA2642152C (en) 2006-02-15 2016-11-01 Coley Pharmaceutical Gmbh Compositions and methods for oligonucleotide formulations
PT2078080E (pt) 2006-09-27 2015-09-18 Coley Pharm Gmbh Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada
RU2009142211A (ru) * 2007-05-17 2011-05-27 Коли Фармасьютикал Груп, Инк. (Us) Класс олигонуклеотидов с иммуностимулирующей активностью
CN101820908A (zh) 2007-10-09 2010-09-01 科利制药公司 包含改性糖部分的免疫刺激寡核苷酸类似物
DK2306986T3 (en) 2008-06-26 2018-06-18 Prolynx Llc PRODRUGS AND PHARMACEUTICAL Macromolecule Conjugates with Controlled Drug Release Rates
JP5209800B2 (ja) 2008-12-09 2013-06-12 ファイザー バクシーンズ エルエルシー IgECH3ペプチドワクチン
AU2009325926B2 (en) 2008-12-09 2013-05-16 Coley Pharmaceutical Group, Inc. Immunostimulatory oligonucleotides
CA2768346A1 (en) 2009-07-30 2011-02-03 Pfizer Vaccines Llc Antigenic tau peptides and uses thereof
PT2575878T (pt) 2010-05-28 2018-10-03 Zoetis Belgium S A Vacinas compreendendo colesterol e cpg como moléculas únicas adjuvante-portador
WO2011154878A1 (en) 2010-06-07 2011-12-15 Pfizer Vaccines Llc Ige ch3 peptide vaccine
SG11201406592QA (en) 2012-05-04 2014-11-27 Pfizer Prostate-associated antigens and vaccine-based immunotherapy regimens
JP6885867B2 (ja) 2014-12-31 2021-06-16 チェックメイト ファーマシューティカルズ, インコーポレイテッド 組合せ腫瘍免疫療法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010140A1 (en) * 1991-11-21 1993-05-27 Pharmagenics, Inc. Oligonucleotides having modified anionic moieties

Also Published As

Publication number Publication date
WO1995001363A1 (de) 1995-01-12
ATE206130T1 (de) 2001-10-15
DE59409880D1 (de) 2001-10-31
JPH08512039A (ja) 1996-12-17
DE4321946A1 (de) 1995-01-12
EP0707591A1 (de) 1996-04-24
FI956341A (fi) 1996-02-19
NO955352L (no) 1996-02-14
NO955352D0 (no) 1995-12-29
CA2165971C (en) 2006-05-30
AU7073594A (en) 1995-01-24
AU698928B2 (en) 1998-11-12
FI115399B (fi) 2005-04-29
FI956341A0 (fi) 1995-12-29
ES2165391T3 (es) 2002-03-16
EP0707591B1 (de) 2001-09-26
JP3831407B2 (ja) 2006-10-11
CA2165971A1 (en) 1995-01-12
US6028182A (en) 2000-02-22
NO319860B1 (no) 2005-09-26
PT707591E (pt) 2002-03-28

Similar Documents

Publication Publication Date Title
DK0707591T3 (da) Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
DE69408666T2 (de) Risperidon pamoate
AU699480B2 (en) 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
IL116385A (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
GEP20022654B (en) Indazole Amide Compounds As Serotoninergic Agents
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
WO2001091738A3 (en) Naaladase inhibitors for treating amyotrophic lateral sclerosis
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
AU686197B2 (en) Use of coumarins and carbostyrils as PLA2-inhibitors, new coumarins and carbostyrils, process for preparing the same and medicaments
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
ES2098119T3 (es) Nuevas triazoloquinazolinas, su obtencion y empleo.